Catalyst Pharmaceuticals (CPRX) announced the appointment of Daniel Curran, MD, to its Board of Directors. Since March 2024, Curran has served as Managing Partner of Mountainfield Venture Partners
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CPRX: